1 completed, 1 recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Recruiting 1 |
Follow SinoMab BioScience Ltd: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Study to Evaluate SM17 for Atopic Dermatitis SM17 for subcutaneous injection, SM17 placebo for subcutaneous injection - Atopic Dermatitis | Phase 2 | Recruiting | SinoMab BioScience Ltd | 200 | 2026-03-31 | 2026-04-06 |
| A Study to Evaluate the Safety and Efficacy of SM03 in Patients With Rheumatoid Arthritis Receiving Methotrexate SM03, Placebo, Methotrexate - Rheumatoid Arthritis | Phase 2 | Completed | SinoMab BioScience Ltd | 156 | 2014-12-31 | 2019-12-10 |
Arthritis, Rheumatoid (1) · Dermatitis, Atopic (1)
Injections, Subcutaneous (1) · Methotrexate (1)
China (2)